Aprea Therapeutics: Gilad Oren, John Hamill buy shares at $0.89 each on 2026-01-30.

Aprea Therapeutics, Inc. (APRE) has disclosed that Director and President/CEO Gilad Oren has acquired 28,100 shares at a price of $0.89 per share on January 30, 2026. Additionally, Senior Vice President, Chief Financial Officer, and Principal Financial & Accounting Officer John P. Hamill has also purchased 5,700 shares at the same price on the same date.